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Intermediate FMR1 alleles and cognitive and/or
behavioural phenotypes
Irene Madrigal1, Mar Xuncla`2, Maria Isabel Tejada3,4, Francisco Martı´nez4,5, Isabel Ferna´ndez-Carvajal4,6,
Luı´s Alberto Pe´rez-Jurado7, Laia Rodriguez-Revenga1 and Montserrat Mila`*,1,4,8
During the last few years, several studies have reported an excess of intermediate FMR1 alleles in patients with cognitive and/or
behavioural phenotypes. Here, we report the frequency of intermediate alleles (IAs) in three pathologies, intellectual disabilities
(IDs), attention-deficit/hyperactivity disorder and autism, from different Spanish regions. We found 142 IAs among 9015
patients with ID (1.6%), 4 among the 415 ADHD patients (0.96%) and 4 among the 300 autistic patients (1.3%), similar to
the frequency reported in our control population. No evidence was found of an excess of IA at the FRAXA locus in any of the
study populations, although geographical variability was detected. Moreover, the analysis of 100 transmissions of IAs showed
that 95% of these alleles were stable. Only 3% expanded within the same range and 2% expanded to a full mutation in two
generations. No evidence of an association between IAs and behavioural or cognitive phenotypes was found, suggesting that
IAs are not clearly implicated in these pathologies.
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INTRODUCTION
Fragile X syndrome (FXS, no. 300624) is the most common form of
inherited intellectual disabilities (IDs), with an estimated incidence of
1 in 4000 males and 1 in 8000 females.1,2 The molecular basis of this
syndrome is mainly the expansion of an unstable region of CGG
repeats in the 5¢-untranslated region of the FXS gene (FMR1). The
CGG repeat of the FMR1 gene is distributed in the population in four
allelic classes. Alleles ranging from 6 to 44 CGG repeats are the most
common in the general population and have stable transmission to the
next generation. Expansion of the repeat region to more than 200
CGG trinucleotide sequences, called full mutation, leads to hyper-
methylation of the CpG island and the expanded CGG region,
resulting in non-expression of the FMR1 gene and absence of the
FMR1 protein (FMRP). The lack of FMRP is the direct cause of the
FXS phenotype.3 Expansions of about 55–200 repeats, called premuta-
tion alleles, are associated with a significant elevation of FMR1 mRNA
levels,4 and it has been known that carriers of FMR1 premutation
have a risk of developing fragile X-associated tremor/ataxia syndrome,
a late-onset neurodegenerative disorder.5,6 Premutation alleles are
generally unstable, resulting in an expansion of the CGG repeat
sequence when passed from mother to child. Offspring of female
premutation carriers is at risk of having FXS. Finally, alleles within the
45–54 CGG repeat range are described as ‘intermediate’ alleles (IAs),
as they may show some instability, including expansion to a full
mutation in two generations,7–9 although they have not been observed
to expand to full mutations in only one generation.
During the last few years, several population studies have been
undertaken to determine the frequency of IA of the FMR1 gene both
in the general population and among persons with ID and/or
behavioural phenotypes. A study of patients with ID in the Brazilian
population10 reported a higher frequency of IA alleles in ID boys
(6.3%) than in normal male controls (2.4%). In a similar study in a
Southern England cohort of ID patients,11 an unexpected excess of IA
alleles of 4% was found compared with 2.4% for controls. However,
other studies failed to replicate these results.12–16
To contribute additional data towards resolving this controversy, we
undertook a survey to determine whether IAs are found at a greater
frequency among a large Spanish cohort of males with behavioural
and/or cognitive phenotypes.
SUBJECTS AND METHODS
Patients
The present study was designed to determine the frequencies of intermediate
FMR1 alleles (defined in the range 45–54 repeats) among 9015 males with ID,
415 males affected by ADHD and 300 males affected with autism spectrum
disorders. Patients were recruited from many different clinical units all over
Spain (Table 1). All patients were referred for fragile X testing, and the
diagnosis of fragile X, ADHD and ASD was performed according to DSM-IV
criteria. Ages ranged from 18 months to 45 years old. All patients provided
informed consent for testing, and the studies were approved by the ethics
committees of each participating institution.
Control population
Frequency of IAs in a control population was determined in a series of 5775
males and 750 women from different Spanish regions (Table 1). The majority of
the controls were already available from previous studies: 256 women from the
general population were recruited in Cruces Hospital (Barakaldo-Bizkaia;
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published by Tejada and Duran17); 496 women from the general population
were recruited in Hospital Universitario La Fe (Valencia); 5500 newborns
(part of these data are published by Fernandez-Carvajal et al18) were recruited
in Universidad de Valladolid (Valladolid) and 275 males from the general
population were recruited in Hospital Clı´nic of Barcelona.
Molecular analysis
Molecular analysis of the FMR1 CGG repeat region was performed in different
laboratories following the same method by PCR amplification using fluorescent-
labelled primers, as previously described.19 The reaction product was analysed on
an ABI310 (Applied Biosystems, Foster City, CA, USA). Data generation and
evaluation have been performed in different centres following similar procedures.
PCR products were purified using the Montage Sequencing Reaction Cleanup
(Millipore Corporation, Billerica, MA, USA), and automatically sequenced using
the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems) and an
ABI3100 automatic sequencer (Applied Biosystems).
Statistical analysis
A Z-test with 95% confidence interval was performed to compare IA frequen-
cies among control and patient populations.
RESULTS
Frequency of IAs in behavioural and/or cognitive phenotypes
A total of 9015 patients with ID, 415 diagnosed with ADHD and 300
with ASD have been tested for the CGG repeat tract of FMR1 gene.
The percentage of IAs was 1.6% (142/9015) among ID patients, 0.98%
(4/415) among ADHD patients and 1.33% (4/300) among ASD
patients. The frequency of IA in males from the general population
was 3.5% (204/5775). No evidence for an excess of IA at the FRAXA
locus in ID, ADHD or ASD populations was detected, but a significant
higher frequency was observed in the control population (Z¼7.598,
Po0.05 for ID; Z¼1.88, Po0.05 for ADHD; and Z¼2.665, Po0.05
for ASD). We investigated whether this fact was because of the
different geographical origin of the samples, as the majority of controls
proceeded from the Northwest and most of the cases were from
the Northeast of Spain. When comparing the frequency of IA in ID
with controls belonging to the same Spanish region, no significant
differences were obtained (Po0.05). The IA frequencies differed
between the four Spanish regions studied, the North of Spain showed
the lowest and Northwest the highest (Table 2). Table 3 shows
the distribution of IA in males with ID and male control samples in
different populations.
Stability of IAs
Analysis of 100 transmissions showed that alleles of 45–54 repeats are
at low risk to expand to full mutations in a single generation. The vast
majority of the IAs remained stable and five were unstable; three of
which expanded within intermediate range (+1–2 CGG) and only two
jumped to full mutation in two generations. A total of 31 IAs,
including 4 of the 5 unstable alleles, were further characterised by
the sequencing of the FMR1-expanded region (Table 4). One of the
alleles that expanded to full mutation in two generations was unin-
terrupted, and the other showed 52 CGG repeats with two AGG
interruptions in a 10-9-31 pattern that expanded to a premutated
allele of 56 CGG, which did not contain any AGG interruptions
(Table 4).
DISCUSSION
The role of FMR1 IA in behavioural and/or cognitive phenotypes is
controversial. Some studies10,11 have reported an excess of these alleles
in ID cohorts, suggesting a possible phenotypic effect in the intellec-
tual functioning. Others, including the present study, have failed to
replicate these results (listed in Table 3). The frequency of IA in the
general population shows geographical variability that ranges from
2.8 to 6.4%. Indeed, differences in FRAXA repeat distributions
have been reported between several ethnic groups, even among
Caucasians.13,20,21 Furthermore, the lack of consensus about the IA
range definition increases this variability among analysed populations.
In the present study, we used an IA range between 45 and 54 repeats,
being the same for patients and controls. A geographical variation was
observed, with the lowest frequency detected in the North of Spain
and the highest in the Northwest. We hypothesise that the high rate of
IA in this population may be due to the low immigration rate in this
region, thereby making this a very closed and autochthonous popula-
tion, in contrast to other regions such as Northeast, North or East of
Spain. In fact, the frequency of IA in Caucasian populations is higher,
for example, than in Africans.13 The low IA frequency observed in the
North could be explained by the presence of ‘pure’ Basque individuals.
Recently, Arrieta et al22 reported that the frequency of IA in a ‘pure’
Basque population was 10%. They established a range for IA within
35–54 CGG; but the frequency of IA within 45–54 used in the present
study was 0%, which may explain the low IA frequency in our North
population.
Table 1 Sample distribution according the geographical origin
Geographical
origin
ID
patients
ADHD
patients
ASD
patients Controls
North 2142# — — 256~
East 1550# — — 494~
Northwest 570# — — 5500#
Northeast 4753# 415# 300# 275#
Total 9015# 415# 300# 5775#/750~
Table 2 Frequency of IA in the Spanish population
IA frequency
in ID patients
IA frequency
in controls
Z-test,
P-value
North 0.8% (17/2142) 0.8% (4/512) 0.255, P40.05
East 1.3% (21/1550) 1.1% (11/988) 0.346, P40.05
Northwest 3.2% (18/570) 3.6% (199/5500) 0.445, P40.05
Northeast 1.8% (86/4753) 1.8% (5/275) 0.221, P40.05
Table 3 Frequency of IA in males with ID and male control samples
in different populations
Population
CGG repeats’
range
IA frequency in
ID patients (%)
IA frequency
in controls (%) Reference
UK 41–60 4.4 2.9a Youings et al11
Brazil 40–60 6.4 2.8a Haddad et al10
Tasmania 41–60 3.4 2.4 Mitchell et al12
USA 41–60 4.3 4.0 Crawford et al13
Canada 40–54 4.2 3.7 Patsalis et al14
Cyprus 40–54 3.5 4.3 Patsalis et al14
France 40–55 2.8 2.2 Mornet et al15
Comparison of studies reported in the literature.
aStatistically significant difference.
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A high frequency of IA has also been associated with an increased
risk of behavioural phenotypes. Specifically, Loesch et al23 found
an association of IA with an increased risk of autistic behaviour.
Nevertheless, considering the small sample size analysed (n¼42),
this affirmation required studies with larger cohorts. In this study,
we determined IA frequency in two independent cohorts of ASD and
ADHD patients, but no significant association was found.
At the FRAXA loci, both the length and the purity of the repeat
have an important role in stability; AGG repeats interrupting the
CGGs are thought to provide stability during replication and hence
avoiding expansion.24 The vast majority of alleles with o45 CGG in
the general population have repeat tracks with two AGG interruptions,
and repeat instabilities are rare for these alleles. Data reported in the
literature show that IA present similar proportions of unstable
transmissions.25,26 In our series, 23 sequenced alleles had two or
more AGG interruptions and 8 had none or only one AGG interrup-
tion, 6 of which remain stable in more than two generations.
Even though the two IA that expanded to full mutation had lost the
AGG interruptions, all alleles lacking an AGG interruption do not
generally expand in the next generation. The loss of the AGG
interruptions could be explained by its conversion to CGG, which
seems to be a common event in human genome.27 The lack of AGG
interruptions, together with other unknown genetic factors, probably
contributed to repeat instability in the two cases as has been studied
by Dombrowski and Morel.26
A frequent concern in FXS screening is the genetic counselling to
IA carriers. Currently, the follow-up of individuals with no AGG
interruptions is indicated, despite the low risk of expansion in the next
generation. Our findings show that IAs should not be considered a
risk factor for ID or behavioural phenotypes. Nonetheless, these alleles
should be characterised to give an accurate genetic counselling.
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Table 4 Stability of intermediate alleles
CGG repeats’ first
generation
CGG repeats’ second
generation
Unstable alleles (n¼4) 46 50 (50)
45 47 (9.9.27)
52 (10.9.31)a 56 (56)
45 (45)a 80 (80)
45 (19.25) —
Stable alleles with one or no 49 (49) —
AGG interruptions (n¼6) 48 (9.38) —
51 (9.41; n¼2) —
54 (9.44) —
45 (9.9.25) —
Stable alleles wit more than 46 (9.9.26) —
one AGG interruption (n¼21) 47 (9.9.27; n¼2) —
48 (9.9.28; n¼4) —
49 (9.9.29; n¼2) —
50 (9.9.8.21) —
50 (9.9.30) —
51 (9.9.31; n¼2) —
52 (9.9.32) —
53 (9.9.33; n¼2) —
54 (9.9.34; n¼3) —
aIA that jumped to full mutation in two generations (published in Fernandez-Carvajal et al8 and
Zuniga et al9). The AGG interspersion pattern is shown in parenthesis.
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